Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

China's growing appeal to the global CRO industry
Fierce Biotech
Monday, April 26, 2010 - 11:01am
tags:
CROs, China, Charles River Laboratories
Global Pharma Sales Steadily Growing Despite Rise of Generics
Seeking Alpha
Monday, April 26, 2010 - 10:18am
tags:
pharmaceutical sales, generics
BioSante inks deal for antibody production technology
Reuters
Monday, April 26, 2010 - 10:16am
tags:
BioSante, antibodies
Shire files lawsuit against Teva
Trading Markets
Monday, April 26, 2010 - 10:07am
tags:
Shire, Teva Pharmaceuticals, lawsuits, Intuniv
Will Pfizer Seek Triple Damages In Protonix Case?
Pharmalot
Monday, April 26, 2010 - 9:59am
tags:
Pfizer, Protolix, patents, Teva Pharmaceuticals, lawsuits
Dendreon Will Run on Provenge OK: Poll
TheStreet.com
Monday, April 26, 2010 - 9:57am
tags:
Dendreon, Provenge, FDA, prostate cancer, vaccines
FDA Leaves Acura Pharma Red-Faced on Lead Product
Seeking Alpha
Monday, April 26, 2010 - 9:54am
tags:
FDA, Acura Pharmaceuticals, King, abuse-resistant painkillers, Acurox
Pfizer Savors a Rare Victory in War Over Whether Viagra Causes Blindness
BNET Pharma
Monday, April 26, 2010 - 9:52am
tags:
Pfizer, Viagra
Merck suffers less than rivals on health reform
Fierce Pharma
Monday, April 26, 2010 - 9:49am
tags:
Merck, healthcare reform
Novartis buys 55,000 Alnylam Pharma shares
Yahoo/AP
Monday, April 26, 2010 - 9:46am
tags:
Novartis, Alnylam, RNA drugs
Takeover Speculation Swarms at AspenBio Pharma
Seeking Alpha
Monday, April 26, 2010 - 9:25am
tags:
AspenBio, Abbott Laboratories, JNJ, Roche
Merck, Nycomed to jointly market COPD treatment
Marketwatch
Monday, April 26, 2010 - 9:22am
tags:
Merck, Nycomed, COPD, partnerships, Daxas
Dr. Reddy's Wins Attorney Fees From AstraZeneca in Prilosec OTC Case
Seeking Alpha
Monday, April 26, 2010 - 9:20am
tags:
Dr Reddy's, lawsuits, settlements, Prilosec, AstraZeneca
Charles River, Chinese Pharma Firm Said To Ink Record Deal
Forbes
Monday, April 26, 2010 - 9:18am
tags:
Charles River Laboratories, WuXi PharmaTech, M&A
Celator(R) Pharmaceuticals Presents New Data on Two Nano-Scale Delivery Platforms at the American Asociation for Cancer Research
PR-CANADA
Sunday, April 25, 2010 - 11:47am
tags:
Celator, CPX-351
Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market
PR-CANADA
Sunday, April 25, 2010 - 11:45am
tags:
Biostar Pharmaceuticals, hepatitis B
The Codexis Story: A Tangled Partnership Web
Seeking Alpha
Sunday, April 25, 2010 - 11:40am
tags:
Codexis
Teva loses Protonix ruling
Globes, Israel
Sunday, April 25, 2010 - 11:39am
tags:
Teva Pharmaceuticals, Protonix, Nycomed
Forest Labs' Reward to Risk Ratio Hits the Spot
Seeking Alpha
Sunday, April 25, 2010 - 11:37am
tags:
Forrest
Seattle biotech firm on verge of a groundbreaking cancer vaccine
The Seattle Times, WA
Sunday, April 25, 2010 - 11:35am
tags:
Dendreon, Provenge, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.